Related references
Note: Only part of the references are listed.NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells
Tao Tao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Clinical Significance and Prognosis Value of Wnt Signaling Pathway in Cervical Cancer
Afsane Bahrami et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance
J. Vaquero et al.
ONCOGENE (2017)
PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation
T. Tao et al.
ONCOGENE (2017)
NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling
Yan Wang et al.
ONCOLOGY REPORTS (2017)
Identification and characterization of HPV- independent cervical cancers
Carolyn E. Banister et al.
ONCOTARGET (2017)
NHERF1 regulates actin cytoskeleton organization through modulation of α-actinin-4 stability
Licui Sun et al.
FASEB JOURNAL (2016)
Wnt signalling in gynaecological cancers: A future target for personalised medicine?
C. E. Ford et al.
GYNECOLOGIC ONCOLOGY (2016)
EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients
Zhiqiang Peng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer
Tao Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
α-Actinin-4 induces the epithelial-to-mesenchymal transition and tumorigenesis via regulation of Snail expression and β-catenin stabilization in cervical cancer
H-T An et al.
ONCOGENE (2016)
Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites
Vjekoslav Tomaic
CANCERS (2016)
Cervical Cancer, Version 2.2015 Featured Updates to the NCCN Guidelines
Wui-Jin Koh et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
The Role of Signaling Pathways in Cervical Cancer and Molecular Therapeutic Targets
Joaquin Manzo-Merino et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer
Ramez N. Eskander et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2014)
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
Renske D. M. Steenbergen et al.
NATURE REVIEWS CANCER (2014)
Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence
Pablo Conesa-Zamora et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation
Wenfang Yao et al.
AMINO ACIDS (2012)
Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis
Andrea Malfettone et al.
BMC CANCER (2012)
Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo
I. Ramachandran et al.
ONCOGENE (2012)
Klotho inhibits the capacity of cell migration and invasion in cervical cancer
Boogi Chang et al.
ONCOLOGY REPORTS (2012)
Distinguishing between nodular and superficial spreading melanoma using specific microRNA alterations.
L. Poliseno et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
E6 and E7 from Human Papillomavirus Type 16 Cooperate To Target the PDZ Protein Na/H Exchange Regulatory Factor 1
Rosita Accardi et al.
JOURNAL OF VIROLOGY (2011)
Beta-Catenin Accelerates Human Papilloma Virus Type-16 Mediated Cervical Carcinogenesis in Transgenic Mice
Guelay Bulut et al.
PLOS ONE (2011)
Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases
Ali Dastranj Tabrizi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
HPV16 E6 augments Wnt signaling in an E6AP-dependent manner
Hava Lichtig et al.
VIROLOGY (2010)
Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
Adhemar Longatto-Filho et al.
BMC CANCER (2009)
NHERF-1: Modulator of Glioblastoma Cell Migration and Invasion
Kerri L. Kislin et al.
NEOPLASIA (2009)
Ras modifies proliferation and invasiveness of cells expressing human papillomavirus oncoproteins
Satoshi Yoshida et al.
JOURNAL OF VIROLOGY (2008)
Wnt signalling and its impact on development and cancer
Alexandra Klaus et al.
NATURE REVIEWS CANCER (2008)
The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells
Rosa A. Cardone et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Proteomics exploration reveals that actin is a signaling target of the kinase Akt
Franck Vandermoere et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Colorectal cancer and genetic alterations in the Wnt pathway
S. Segditsas et al.
ONCOGENE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Activation of the canonical Wnt pathway during genital keratinocyte transformation:: A model for cervical cancer progression
A Üren et al.
CANCER RESEARCH (2005)
EBP50, a β-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma
T Shibata et al.
HEPATOLOGY (2003)
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation
M Thomas et al.
ONCOGENE (2002)
Share Paper
